BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35066680)

  • 21. Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series.
    Lin HY; Chuang CK; Wang CH; Chien YH; Wang YM; Tsai FJ; Chou YY; Lin SJ; Pan HP; Niu DM; Hwu WL; Ke YY; Lin SP
    Mol Genet Metab Rep; 2016 Jun; 7():63-9. PubMed ID: 27134829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individualized evaluation of lumbar bone mineral density in children with cerebral palsy.
    Duran I; Katzmann J; Martakis K; Stark C; Semler O; Schoenau E
    Arch Osteoporos; 2018 Nov; 13(1):120. PubMed ID: 30397843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
    Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent bone and joint disease despite current treatments for mucopolysaccharidosis types I, II, and VI: Data from a 10-year prospective study.
    Miller BS; Fung EB; White KK; Lund TC; Harmatz P; Orchard PJ; Whitley CB; Polgreen LE
    J Inherit Metab Dis; 2023 Jul; 46(4):695-704. PubMed ID: 36840680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should 25-hydroxyvitamin D and bone density using DXA be tested in adolescents with lumbar stress fractures of the pars interarticularis?
    McClellan JW; Vernon BA; White MA; Stamm S; Ryschon KL
    J Spinal Disord Tech; 2012 Dec; 25(8):426-8. PubMed ID: 22134731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inaccuracies inherent in dual-energy X-ray absorptiometry in vivo bone mineral densitometry may flaw osteopenic/osteoporotic interpretations and mislead assessment of antiresorptive therapy effectiveness.
    Bolotin HH
    Bone; 2001 May; 28(5):548-55. PubMed ID: 11344055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in pediatric DXA measures of musculoskeletal outcomes and correlation with quantitative CT following treatment of acute lymphoblastic leukemia.
    Mostoufi-Moab S; Kelly A; Mitchell JA; Baker J; Zemel BS; Brodsky J; Long J; Leonard MB
    Bone; 2018 Jul; 112():128-135. PubMed ID: 29679731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Size-adjustment techniques of lumbar spine dual energy X-ray absorptiometry measurements in assessing bone mineralization in children on maintenance hemodialysis.
    Salem N; Bakr A
    J Pediatr Endocrinol Metab; 2021 Oct; 34(10):1291-1302. PubMed ID: 34273916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced spinal bone mineral density in adolescents of an Ultra-Orthodox Jewish community in Brooklyn.
    Taha W; Chin D; Silverberg AI; Lashiker L; Khateeb N; Anhalt H
    Pediatrics; 2001 May; 107(5):E79. PubMed ID: 11331729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
    Rahim A; Holmes SJ; Adams JE; Shalet SM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose.
    Lachman RS; Burton BK; Clarke LA; Hoffinger S; Ikegawa S; Jin DK; Kano H; Kim OH; Lampe C; Mendelsohn NJ; Shediac R; Tanpaiboon P; White KK
    Skeletal Radiol; 2014 Mar; 43(3):359-69. PubMed ID: 24389823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.
    Matsubara Y; Miyazaki O; Kosuga M; Okuyama T; Nosaka S
    Pediatr Radiol; 2017 Nov; 47(12):1659-1669. PubMed ID: 28733853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of bone mineral density with dual x-ray absorptiometry for osteoporosis in children with bladder augmentation.
    Abeş M; Sarihan H; Madenci E
    J Pediatr Surg; 2003 Feb; 38(2):230-2. PubMed ID: 12596110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy.
    Pal AR; Mercer J; Jones SA; Bruce IA; Bigger BW
    PLoS One; 2018; 13(9):e0203216. PubMed ID: 30226843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI.
    Byers S; Nuttall JD; Crawley AC; Hopwood JJ; Smith K; Fazzalari NL
    Bone; 1997 Nov; 21(5):425-31. PubMed ID: 9356736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI.
    Furujo M; Kubo T; Kosuga M; Okuyama T
    Mol Genet Metab; 2011 Dec; 104(4):597-602. PubMed ID: 21930407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone health of patients with juvenile idiopathic arthritis: a comparison between dual-energy X-ray absorptiometry and digital X-ray radiogrammetry.
    Nusman CM; Anink J; Otten MH; van Rossum MA; van Rijn RR; Maas M; van Suijlekom-Smit LW
    Eur J Radiol; 2015 Oct; 84(10):1999-2003. PubMed ID: 26116967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lumbar spine bone mineral density Z-score discrepancies by dual X-ray absorptiometry do not predict vertebral fractures in children.
    Harindhanavudhi T; Petryk A; Jones R; Regodón Wallin A; Hodges JS; Nortwick SV; Miller BS; Holm TL; Sarafoglou K
    J Investig Med; 2018 Aug; 66(6):980-985. PubMed ID: 29622758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac structure and function and effects of enzyme replacement therapy in patients with mucopolysaccharidoses I, II, IVA and VI.
    Lin HY; Chuang CK; Chen MR; Lin SM; Hung CL; Chang CY; Chiu PC; Tsai WH; Niu DM; Tsai FJ; Lin SJ; Hwu WL; Lin JL; Lin SP
    Mol Genet Metab; 2016 Apr; 117(4):431-7. PubMed ID: 26899310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.